Drug reshapes tissue architecture to reduce damage in alcohol-related liver disease
A new study has shed light on how a type of drug works to reduce liver damage in alcohol-related liver disease, by reshaping the architecture of the tissue. The findings could pave the way for the development of new treatments for liver disease and improve outcomes for patients.




















